An agenda built through deep collaboration with our community to ensure every session delivers substance over soundbites. You’ll hear from true subject matter leaders via candid case studies, collaborative panels, and varied panel discussions —providing clarity on what’s driving success across the customer engagement landscape
- Learn how two sales leaders built trust and drove adoption across their teams, from recruiting the right pilot champions to scaling AI into everyday practice
- Discover how AI-generated interaction insights are reshaping self-development, giving reps a clearer, more objective path to what's driving HCP behavior change
- See how organizations are using APEX* Pharma Sentiment Score to inform strategy in real-time, driving continuous improvement all while being able to benchmark against industry peers.
*ADVANCE AI Pharma Emotive IndeX
Â
Ryan Beaird, Senior Area General Manager, Bayer
Deanna Olson, Senior Area General Manager, Bayer
- Strengthen patient relationships by shifting from channel-level fixes to a true operating model
- Maximize direct-to-patient value by treating this as a systems design challenge, not a content or technology gap
- Close the gap between initiatives that look strong on day one and models built to hold up as direct-to-patient relationships scale
Â
Silvi Haldipur, Head of Customer Experience Strategy and Human Centered Design, Novo Nordisk
Amy Turnquist, VP, the America's Operating Board, Healthcare Businesswomen’s Association
- Redefine customer interactions by shifting from rigid CRM journeys to intelligent platforms that adapt dynamically to context, timing, and intentÂ
- Drive commercial growth through AI segmentation capabilities that anticipate patient journeys and predict prescribing patterns before they occurÂ
Darshan Joshi, Head of Commercial Technology Blueprint Transformation, USBU & OBU, Takeda
Elizabeth Beringer, President, Real Chemistry
Moderator:Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Build a trusted, connected data foundation across HCP, patient, payer, field, and omnichannel engagement data.
- Turn fragmented commercial data into actionable insights that improve targeting, next-best actions, and customer experience.
- Establish the governance, quality, privacy, and compliance controls needed to scale AI responsibly in life sciences.
- Move from AI experimentation to measurable commercial impact—accelerating launch readiness, brand performance, and field effectiveness
Sainath Kumar, Associate Partner (AI & Analytics Lead), IBMÂ
 From prescription to patient journey: Orchestrate end-to-end value through data, technology and cross-functional alignmentÂ
- Deploy RWE and patient-outcomes data to reframe HCP perception, proving holistic care impact beyond clinical endpoints
- Equip MSLs, reps, and brand teams with role-specific, data-powered playbooks to deliver a unified value narrative across home care, decentralized diagnostics, reimbursement, and access
- Leverage data platforms to transform everyday patient behavior into commercial-ready evidence that bridges trial endpoints and lived experience
Saket Malhotra, Global Head of Commercial Digital, BioMarin
Holly Valdiviez, Senior Vice President, Neuropsychiatry Franchise, Acadia Pharmaceuticals
Lauren Cole, Chief Strategy Officer, Valeris
Moderator: Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Discover how the Giants are re-defining their digital offerings to reach emerging audiences through specialized content and platform strategy
- Learn how the team is enhancing in-person events into unique digital experiences
Â
David Dominik, Vice President, Digital Strategy, New York Football Giants
- Strengthen precision targeting by translating observed HCP behaviors into actionable segments, clearly distinguishing direct evidence from proxies and projections
- Drive measurable impact by connecting segmentation to relevant messaging and coordinated field and digital engagement
Â
Akash Jain, Director, Data & Analytics Strategy (US Oncology), Merck
- Re-architect AI-enabled infrastructure and teams to increase organizational agility while maintaining regulatory separation Â
- Apply human-centered AI and purposeful analytics to cut through digital noise, surface actionable insights, and accelerate compliant decision-makingÂ
Anuvrat Chaturvedi, Senior Director, Data Science, Gilead Sciences
Vaishali Chaudhuri, Director Marketing Sciences, Gilead Sciences
- Accelerate performance by shifting from a reach-focused to a trigger-based engagement strategy to improve customer experience and engagement
- Optimize channel mix and HCP activation using triggers, dynamic affinity data, and precision media to engage at critical decision-making moments
Kevin O'Connell, VP, Business Solutions, PharmaForceIQ
- The blind spot in HCP targeting: Most targeting models are built on retrospective claims analysis — a record of where patients ended up, not how they actually experienced their disease. We'll examine why this backward-looking approach systematically misdirects commercial strategy.
- Clinical intent as the missing layer: Introducing clinical intent — a more holistic way to read disease experience and identify the right patient cohort before asking which HCPs to target, rather than reverse-engineering targeting from historical claims patterns.
- Operationalizing Patient First, Doctor Second: What this reordering means in practice — for data strategy, cohort definition, and how commercial teams should rethink the sequence of who they study first.
Scott Phillips, Vice President, Real World Data Diaceutics, Diaceutics
- Deliver more relevant customer interactions by deploying tailored engagement models that address specific needs across diverse segments
- Maximize reach and impact by implementing flexible frameworks that adapt to varying stakeholder levels
Johanna Rossell, SVP, General Manager, Regenerative Medicine, Sumitomo Pharma America
Brenden Schultek, VP of Sales, Merz Therapeutics
Moderator: Mike Zapiec, Consulting Executive, Inizio Ignite
Redefine the field: Deploy needs-first engagement and customer-led discovery to build strategic partnerships
- Build trust by reorienting field strategy from sales-based to needs-first engagement approachesÂ
- Strengthen long-term partnerships by installing listening frameworks and discovery tools that transform field teams from message-bearers to strategic partnersÂ
Veronica Gindel, Vice President, Sales, Uro-Oncology, Ferring Pharmaceuticals
Baya Ginn, Founder, SCD Relief Inc. (a non-profit serving patients with sickle cell disease)
Parth Khanna, CEO and Co-founder, ACTO
Moderator: Mayank Agrawal, Regional Marketing Leader, Hematology, AstraZeneca
- Harness agentic AI, from everyday workflows to strategy formulation, to sharpen the commercial decisions that drive revenue growth, launch speed, and sales force productivity
- Extend AI beyond commercial performance into market access and patient impact, turning cross-functional insights into stronger access strategies and outcomes that matter to patients
Izumi Yoshida, Executive Officer, Head of Pharma, GenerativeX
Philippe Sauvage, Chief Financial Officer, Nuvaction Bio
Interactive workshop 2: From siloed to seamless: How data connectivity unlocks the real-world consumer, patient, and HCP journey
- Healthcare and pharma marketers have more data than ever — yet the consumer, patient, and HCP journey often remains fragmented across disconnected 1st, 2nd, and 3rd-party sources
- This session explores how data connectivity, not just data volume, is the key to overcoming that fragmentation
- Attendees will learn how securely linking owned, partner, and external data sources creates a unified, longitudinal view of the journey — from awareness through diagnosis, treatment, and prescribing behavior
- The discussion will cover what effective data connectivity requires in practice, and how organizations can translate a connected view into sharper targeting, better measurement, and superior real-world business outcomes
Â
Jason Brenner, RVP, Healthcare & Life Sciences, LiveRamp
Matthew Hogg, Senior Vice President, Connectivity & Ecosystem, LiveRamp
- Elevate engagement quality by fusing NBA precision with value-driven content strategies that address real customer priorities instead of relying solely on channel optimizationÂ
- Drive operational excellence by integrating omnichannel delivery, AI MLR acceleration and tiered approval systems into one cohesive personalization engine that scales impactÂ
Nivi Mogali, Director, Enterprise Omnichannel Analytics Capabilities, GSK
Vijay Iyengar, Executive Director, Global Digital Business Transformation: Sales, Marketing & Enterprise Strategy, Eisai
Erin Gallagher, Principal, Customer Success, Veeva Ostro
Moderator: Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Scale analytics capabilities enterprise-wide through systematic capability building that empowers data-driven decision making with confidenceÂ
- Improve post-launch performance by leveraging predictive models that identify opportunities and risks in real timeÂ
Marilina Marcano, Marilina Marcano, Executive Director, US Product Strategy Lead, General Management, US Oncology, Novartis
Ridhima Sharma, Global Marketing Director, (Global Neurology), Sanofi
Jaspreet Singh, Chief Customer Officer, Empower Pharmacy
- Map the structural parallels between underrepresented leadership pathways in pharma and underrepresented customer voices in the healthcare ecosystem — identifying the shared patterns of "fewer peers, fewer channels, more friction"
- Translate personal leadership strategies — built from navigating rooms with limited access or sponsorship — into concrete tactics for building trust and influence with underserved HCP and patient populations
- Co-create at least one practical, cross-functional approach (commercial, medical, or engagement) that teams can pilot to authentically reach a specific underrepresented HCP or patient segment
- Commit to a personal or team-level action step — walking away with both a peer network and a concrete next move to bring back to their organization
- Evolving omnichannel strategies to include a broader group of customer-facing roles (including account leads, sales reps, MSLs, TLLs, reimbursement specialists) with a compelling value proposition for each team member
- Uncover meaningful and actionable customer insights that connect human and digital experiences, driving field impact at each customer interaction
- Align field and omnichannel teams around common business objectives, KPIs, and accountability. Establish feedback loops to continuously optimize engagement and outcomes
Tarak Shah, Omnichannel strategy leader
Jane Urban, Chief Data and Analytics Officer (CDAO), Improzo
- Dismantle functional silos and organize around the customer ecosystem by building a closed strategy-to-field feedback loop that connects enterprise priorities with coordinated cross-functional execution
- Accelerate insight-to-action at scale by embedding AI-driven customer diagnostics into a shared operating model that continuously translates field learning into adaptive commercial strategy
Jill Shull Gildroy, Executive Director, CAR-T Business Excellence, NovartisÂ
- Explore the forces that turned GLP-1 market into a blueprint for consumer-driven healthcare
- Identify the implications for commercial leaders as the lessons from the GLP-1 market reshape forecasting, value propositions, customer engagement, and future launch strategies
Chareen Lim, Senior Vice President, Ipsos
-Detect emerging adoption barriers early with real-world data, and act on the signals before they derail intervention outcomes
-Strengthen adherence results by deploying agile measurement systems that trigger immediate program adjustments based on behavioral data
Wes Little, Chief Analytics & Data Officer, GM, WellSky
Matt Wilson, Founder and CEO, uMed
- Accelerate decision-making by delivering on-demand, real-time analytics that enable medical and commercial teams to act faster without waiting for manual data requests or approvals
- Drive measurable business outcomes by translating shared insights into automated workflows that reduce time-to-action and improve consistency across functions
Nadia Tantsyura, Executive Director, Commercial AI & Advanced Analytics, Bristol Myers Squibb
Philip Poulidis, CEO & Co-Founder, ODAIA
Moderator: Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Drive strategic alignment by leveraging AI-powered intelligence layers that grant appropriate visibility to medical and commercial teams while respecting access protocols
- Optimize cross-functional performance by building data-sharing frameworks that eliminate silos without breaching regulatory separation requirements
Wincy Fung, AVP, Digital Services, Digital MMD, Merck
Eddie Power, VP, Global Pharma Medical Strategy, Bausch Health
Moderator: Ketul Shah, Insights and Optimization Lead, Novo Nordisk
Is your DTC strategy strengthening patient engagement, or creating a new disconnect in the healthcare journey?
- Unlock the direct-to-consumer opportunity: Learn how leading pharma organizations are building trusted, personalized patient relationships beyond traditional HCP engagement models through digital, telehealth, and direct-to-patient ecosystems.
- Turn consumer engagement into measurable impact: Discover how to connect consumer data, patient experience, access, and adherence strategies to drive faster therapy initiation, improved outcomes, and sustainable commercial growth.Â
- Use the data you have to achieve the full Know → Decide → Improve → Succeed chain for your AI investments by:
- Transforming the usage data from your AI tools through a measurement framework that reveals use, adoption, quality and impact across AI platforms.
- Managing experimentation as a pipeline into institutionalization, scaling, keeping or retiring automations and agentic workflows on performance, cost and uptake.
- Raising quality and containing risk on both the user side and the system side, to maximize impact and ROI.
David Bernard, Managing Director, DB Marketing Technologies
-Accelerate organizational performance by embedding AI-enabled tools and role-specific intelligence that empower teams to scale meaningful, compliance-ready HCP engagement
-Build hybrid team structures that blend human expertise with agentic AI to scale consistent, outcome-led personalization across every HCP touchpoint
Rachel Aldana, VP Head of Commercial Operations, AbiVax
Michael Sobotka, VP, Data Science - Global Commercial Analytics, Pfizer
Andreas Lehmann, Head, Cardiovascular Disease Prevention, US Commercial Lead Cardio-Inflammation, Novartis
Moderator: Nadine Lafond, CEO, Imre C46
- Learn how two sales leaders built trust and drove adoption across their teams, from recruiting the right pilot champions to scaling AI into everyday practice
- Discover how AI-generated interaction insights are reshaping self-development, giving reps a clearer, more objective path to what's driving HCP behavior change
- See how organizations are using APEX* Pharma Sentiment Score to inform strategy in real-time, driving continuous improvement all while being able to benchmark against industry peers.
*ADVANCE AI Pharma Emotive IndeX
Â
Ryan Beaird, Senior Area General Manager, Bayer
Deanna Olson, Senior Area General Manager, Bayer
- Strengthen patient relationships by shifting from channel-level fixes to a true operating model
- Maximize direct-to-patient value by treating this as a systems design challenge, not a content or technology gap
- Close the gap between initiatives that look strong on day one and models built to hold up as direct-to-patient relationships scale
Â
Silvi Haldipur, Head of Customer Experience Strategy and Human Centered Design, Novo Nordisk
Amy Turnquist, VP, the America's Operating Board, Healthcare Businesswomen’s Association
- Redefine customer interactions by shifting from rigid CRM journeys to intelligent platforms that adapt dynamically to context, timing, and intentÂ
- Drive commercial growth through AI segmentation capabilities that anticipate patient journeys and predict prescribing patterns before they occurÂ
Â
Darshan Joshi, Head of Commercial Technology Blueprint Transformation, USBU & OBU, Takeda
Elizabeth Beringer, President, Real Chemistry
Moderator:Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Build a trusted, connected data foundation across HCP, patient, payer, field, and omnichannel engagement data.
- Turn fragmented commercial data into actionable insights that improve targeting, next-best actions, and customer experience.
- Establish the governance, quality, privacy, and compliance controls needed to scale AI responsibly in life sciences.
- Move from AI experimentation to measurable commercial impact—accelerating launch readiness, brand performance, and field effectiveness
Sainath Kumar, Associate Partner (AI & Analytics Lead), IBM
 From prescription to patient journey: Orchestrate end-to-end value through data, technology and cross-functional alignment
- Deploy RWE and patient-outcomes data to reframe HCP perception, proving holistic care impact beyond clinical endpoints
- Equip MSLs, reps, and brand teams with role-specific, data-powered playbooks to deliver a unified value narrative across home care, decentralized diagnostics, reimbursement, and access
- Leverage data platforms to transform everyday patient behavior into commercial-ready evidence that bridges trial endpoints and lived experience
Â
Saket Malhotra, Global Head of Commercial Digital, BioMarin
Holly Valdiviez, Senior Vice President, Neuropsychiatry Franchise, Acadia Pharmaceuticals
Lauren Cole, Chief Strategy Officer, Valeris
Moderator: Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Discover how the Giants are re-defining their digital offerings to reach emerging audiences through specialized content and platform strategy
- Learn how the team is enhancing in-person events into unique digital experiences
Â
David Dominik, Vice President, Digital Strategy, New York Football Giants
- Use the data you have to achieve the full Know → Decide → Improve → Succeed chain for your AI investments by:
- Transforming the usage data from your AI tools through a measurement framework that reveals use, adoption, quality and impact across AI platforms.
- Managing experimentation as a pipeline into institutionalization, scaling, keeping or retiring automations and agentic workflows on performance, cost and uptake.
- Raising quality and containing risk on both the user side and the system side, to maximize impact and ROI.
David Bernard, Managing Director, DB Marketing Technologies
-Accelerate organizational performance by embedding AI-enabled tools and role-specific intelligence that empower teams to scale meaningful, compliance-ready HCP engagement
-Build hybrid team structures that blend human expertise with agentic AI to scale consistent, outcome-led personalization across every HCP touchpoint
Rachel Aldana, VP Head of Commercial Operations, AbiVax
Michael Sobotka, VP, Data Science - Global Commercial Analytics, Pfizer
Andreas Lehmann, Head, Cardiovascular Disease Prevention, US Commercial Lead Cardio-Inflammation, Novartis
Moderator: Nadine Lafond, CEO, Imre C46
- Strengthen precision targeting by translating observed HCP behaviors into actionable segments, clearly distinguishing direct evidence from proxies and projections
- Drive measurable impact by connecting segmentation to relevant messaging and coordinated field and digital engagement
Â
Akash Jain, Director, Data & Analytics Strategy (US Oncology), Merck
- Accelerate performance by shifting from a reach-focused to a trigger-based engagement strategy to improve customer experience and engagement
- Optimize channel mix and HCP activation using triggers, dynamic affinity data, and precision media to engage at critical decision-making moments
Kevin O'Connell, VP, Business Solutions, PharmaForceIQ
- Deliver more relevant customer interactions by deploying tailored engagement models that address specific needs across diverse segments
- Maximize reach and impact by implementing flexible frameworks that adapt to varying stakeholder levels
Â
Johanna Rossell, SVP, General Manager, Regenerative Medicine, Sumitomo Pharma America
Brenden Schultek, VP of Sales, Merz Therapeutics
Moderator: Mike Zapiec, Consulting Executive, Inizio Ignite
- Elevate engagement quality by fusing NBA precision with value-driven content strategies that address real customer priorities instead of relying solely on channel optimizationÂ
- Drive operational excellence by integrating omnichannel delivery, AI MLR acceleration and tiered approval systems into one cohesive personalization engine that scales impactÂ
Â
Nivi Mogali, Director, Enterprise Omnichannel Analytics Capabilities, GSK
Vijay Iyengar, Executive Director, Global Digital Business Transformation: Sales, Marketing & Enterprise Strategy, Eisai
Erin Gallagher, Principal, Customer Success, Veeva Ostro
Moderator: Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Evolving omnichannel strategies to include a broader group of customer-facing roles (including account leads, sales reps, MSLs, TLLs, reimbursement specialists) with a compelling value proposition for each team member
- Uncover meaningful and actionable customer insights that connect human and digital experiences, driving field impact at each customer interaction
- Align field and omnichannel teams around common business objectives, KPIs, and accountability. Establish feedback loops to continuously optimize engagement and outcomes
Â
Tarak Shah, Omnichannel strategy leader
Jane Urban, Chief Data and Analytics Officer (CDAO), Improzo
- Explore the forces that turned GLP-1 market into a blueprint for consumer-driven healthcare
- Identify the implications for commercial leaders as the lessons from the GLP-1 market reshape forecasting, value propositions, customer engagement, and future launch strategies
Chareen Lim, Senior Vice President, Ipsos
- Accelerate decision-making by delivering on-demand, real-time analytics that enable medical and commercial teams to act faster without waiting for manual data requests or approvals
- Drive measurable business outcomes by translating shared insights into automated workflows that reduce time-to-action and improve consistency across functions
Nadia Tantsyura, Executive Director, Commercial AI & Advanced Analytics, Bristol Myers Squibb
Philip Poulidis, CEO & Co-Founder, ODAIA
Moderator: Matt Atkinson, Head of Sales & Partnership, Pharma and Healthcare, Reuters Events
- Re-architect AI-enabled infrastructure and teams to increase organizational agility while maintaining regulatory separation Â
- Apply human-centered AI and purposeful analytics to cut through digital noise, surface actionable insights, and accelerate compliant decision-makingÂ
Â
Anuvrat Chaturvedi, Senior Director, Data Science, Gilead Sciences
Vaishali Chaudhuri, Director Marketing Sciences, Gilead Sciences
- The blind spot in HCP targeting: Most targeting models are built on retrospective claims analysis — a record of where patients ended up, not how they actually experienced their disease. We'll examine why this backward-looking approach systematically misdirects commercial strategy.
- Clinical intent as the missing layer: Introducing clinical intent — a more holistic way to read disease experience and identify the right patient cohort before asking which HCPs to target, rather than reverse-engineering targeting from historical claims patterns.
- Operationalizing Patient First, Doctor Second: What this reordering means in practice — for data strategy, cohort definition, and how commercial teams should rethink the sequence of who they study first.
Â
Scott Phillips, Vice President, Real World Data Diaceutics, Diaceutics
Redefine the field: Deploy needs-first engagement and customer-led discovery to build strategic partnerships
- Build trust by reorienting field strategy from sales-based to needs-first engagement approachesÂ
- Strengthen long-term partnerships by installing listening frameworks and discovery tools that transform field teams from message-bearers to strategic partnersÂ
Veronica Gindel, Vice President, Sales, Uro-Oncology, Ferring Pharmaceuticals
Baya Ginn, Founder, SCD Relief Inc. (a non-profit serving patients with sickle cell disease)
Parth Khanna, CEO and Co-founder, ACTO
Moderator: Mayank Agrawal, Regional Marketing Leader, Hematology, AstraZeneca
- Dismantle functional silos and organize around the customer ecosystem by building a closed strategy-to-field feedback loop that connects enterprise priorities with coordinated cross-functional execution
- Accelerate insight-to-action at scale by embedding AI-driven customer diagnostics into a shared operating model that continuously translates field learning into adaptive commercial strategy
Jill Shull Gildroy, Executive Director, CAR-T Business Excellence, Novartis
-Detect emerging adoption barriers early with real-world data, and act on the signals before they derail intervention outcomes
-Strengthen adherence results by deploying agile measurement systems that trigger immediate program adjustments based on behavioral data
Â
Wes Little, Chief Analytics & Data Officer, GM, WellSky
Matt Wilson, Founder and CEO, uMed
- Drive strategic alignment by leveraging AI-powered intelligence layers that grant appropriate visibility to medical and commercial teams while respecting access protocols
- Optimize cross-functional performance by building data-sharing frameworks that eliminate silos without breaching regulatory separation requirements
Wincy Fung, AVP, Digital Services, Digital MMD, Merck
Eddie Power, VP, Global Pharma Medical Strategy, Bausch Health
Moderator: Ketul Shah, Insights and Optimization Lead, Novo Nordisk
- Harness agentic AI, from everyday workflows to strategy formulation, to sharpen the commercial decisions that drive revenue growth, launch speed, and sales force productivity
- Extend AI beyond commercial performance into market access and patient impact, turning cross-functional insights into stronger access strategies and outcomes that matter to patients
Â
Izumi Yoshida, Executive Officer, Head of Pharma, GenerativeX
Philippe Sauvage, Chief Financial Officer, Nuvaction Bio
Interactive workshop 2: From siloed to seamless: How data connectivity unlocks the real-world consumer, patient, and HCP journey
- Healthcare and pharma marketers have more data than ever — yet the consumer, patient, and HCP journey often remains fragmented across disconnected 1st, 2nd, and 3rd-party sources
- This session explores how data connectivity, not just data volume, is the key to overcoming that fragmentation
- Attendees will learn how securely linking owned, partner, and external data sources creates a unified, longitudinal view of the journey — from awareness through diagnosis, treatment, and prescribing behavior
- The discussion will cover what effective data connectivity requires in practice, and how organizations can translate a connected view into sharper targeting, better measurement, and superior real-world business outcomes
Jason Brenner, RVP, Healthcare & Life Sciences, LiveRamp
Matthew Hogg, Senior Vice President, Connectivity & Ecosystem, LiveRamp
- Map the structural parallels between underrepresented leadership pathways in pharma and underrepresented customer voices in the healthcare ecosystem — identifying the shared patterns of "fewer peers, fewer channels, more friction"
- Translate personal leadership strategies — built from navigating rooms with limited access or sponsorship — into concrete tactics for building trust and influence with underserved HCP and patient populations
- Co-create at least one practical, cross-functional approach (commercial, medical, or engagement) that teams can pilot to authentically reach a specific underrepresented HCP or patient segment
- Commit to a personal or team-level action step — walking away with both a peer network and a concrete next move to bring back to their organization
Is your DTC strategy strengthening patient engagement, or creating a new disconnect in the healthcare journey?
- Unlock the direct-to-consumer opportunity: Learn how leading pharma organizations are building trusted, personalized patient relationships beyond traditional HCP engagement models through digital, telehealth, and direct-to-patient ecosystems.
- Turn consumer engagement into measurable impact: Discover how to connect consumer data, patient experience, access, and adherence strategies to drive faster therapy initiation, improved outcomes, and sustainable commercial growth.Â
